Skip to main content
Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024

Agile Therapeutics Revenue

Agile Therapeutics had revenue of $5.58M in the quarter ending June 30, 2024, with 1.33% growth. This brings the company's revenue in the last twelve months to $21.57M, up 32.22% year-over-year. In the year 2023, Agile Therapeutics had annual revenue of $19.59M with 80.02% growth.

Revenue (ttm)
$21.57M
Revenue Growth
+32.22%
P/S Ratio
0.31
Revenue / Employee
$1,135,211
Employees
19
Market Cap
10.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.59M8.71M80.02%
Dec 31, 202210.88M6.78M165.40%
Dec 31, 20214.10M3.35M447.53%
Dec 31, 2020749.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AGRX News

More News